Overview

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Multi-center, single-blind, randomized, comparative, split-face study. The duration of the study is 8 weeks. Commencing at baseline, subjects will apply once daily both clindamycin and benzoyl peroxide gel and benzoyl peroxide/adapalene gel in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. After visit 3, subjects will commence application of clindamycin and benzoyl peroxide gel to the entire face for an additional 6 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Adapalene
Adapalene, Benzoyl Peroxide Drug Combination
Benzoyl Peroxide
Clindamycin
Clindamycin palmitate
Clindamycin phosphate